|
Biologics May Get Break on Early Notification Mandates
Biologics, like small-molecule drugs, may get a break on early shortage notification requirements as the reconciled FDA user fee bill gives the agency enforcement discretion for these products.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives